ANISH BHATNAGAR (President and CEO) sold 13.4% of their position (115K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $5.45M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/30/2024ACC: 0001415889-24-022648
DirectorOfficer· President and CEO
Since Jan 2019
-115K
Net shares
Net seller
$5.45M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
115K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−30.26K
Price / share
$47.19
Trade value
$1.43M
% of position
3.5%
8/28/2024
856.19K→825.93K
Common Stock
Direct
Shares
−26.35K
Price / share
$48.03
Trade value
$1.27M
% of position
3.2%
8/28/2024
825.93K→799.58K
Common Stock
Direct
Shares
−47.55K
Price / share
$47.16
Trade value
$2.24M
% of position
5.9%
8/29/2024
799.58K→752.03K
Common Stock
Direct
Shares
−10.84K
Price / share
$47.83
Trade value
$518.51K
% of position
1.4%
8/29/2024
752.03K→741.19K
Total
Net shares
−115K
Net value
-$5.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2024 | S · Sale | −30.26K | $47.19 | $1.43M | 3.5% | 856.19K | 825.93K |
| Common Stock Direct | 8/28/2024 | S · Sale | −26.35K | $48.03 | $1.27M | 3.2% | 825.93K | 799.58K |
| Common Stock Direct | 8/29/2024 | S · Sale | −47.55K | $47.16 | $2.24M | 5.9% | 799.58K | 752.03K |
| Common Stock Direct | 8/29/2024 | S · Sale | −10.84K | $47.83 | $518.51K | 1.4% | 752.03K | 741.19K |
| Total | −115K | -$5.45M | ||||||
Derivative Transactions0
No derivative transactions reported